Color Gets Green Light for LAMP-Based COVID-19 Screening Test

Source: FierceBiotech

Genomic testing firm Color received an emergency authorization from the FDA for its scalable COVID-19 screening method, which differs from the standard PCR-based technologies widely used so far, according to a FierceBiotech report.

Employing the LAMP process, for loop-mediated isothermal amplification, the molecular test uses a consistent temperature to drive the replication of different segments of the novel coronavirus’s genome—establishing a positive signal without the multiple cycles of heating and cooling and extra hardware required for PCR. 

Read the full article.

Related Content